Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Edoardo Spina

Section of Pharmacology

Department of Clinical and Experimental Medicine and Pharmacology

University of Messina

Messina

Italy

[email]@unime.it

Name/email consistency: high

[Claim this account]

Affiliations

Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Messina, Italy. 2001 - 2012
Department of Pharmaceutical Sciences, University of Catania, Italy. 2011

References

Clinically significant drug interactions with newer antidepressants. Spina, E., Trifirò, G., Caraci, F. CNS. Drugs (2012) [Pubmed]
Metabolic Drug Interactions between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract. Caraci, F., Crupi, R., Drago, F., Spina, E. Curr. Drug Metab. (2011) [Pubmed]
Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder. Spina, E., D'Arrigo, C., Santoro, V., Muscatello, M.R., Pandolfo, G., Zoccali, R., Diaz, F.J., de Leon, J. Ther. Drug. Monit (2009) [Pubmed]
Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia. Spina, E., Zoccali, R. Expert. Opin. Drug. Metab. Toxicol (2008) [Pubmed]
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Spina, E., Santoro, V., D'Arrigo, C. Clin. Ther (2008) [Pubmed]
Metabolic drug interactions with newer antipsychotics: a comparative review. Spina, E., de Leon, J. Basic Clin. Pharmacol. Toxicol. (2007) [Pubmed]
The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia. Spina, E., Cavallaro, R. Expert. Opin. Drug. Saf (2007) [Pubmed]
Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder. Spina, E., D'Arrigo, C., Migliardi, G., Santoro, V., Muscatello, M.R., Micò, U., D'Amico, G., Perucca, E. Ther. Drug. Monit (2006) [Pubmed]
Antiepileptic drugs: indications other than epilepsy. Spina, E., Perugi, G. Epileptic. Disord (2004) [Pubmed]
Plasma risperidone concentrations during combined treatment with sertraline. Spina, E., D'Arrigo, C., Migliardi, G., Morgante, L., Zoccali, R., Ancione, M., Madia, A. Ther. Drug. Monit (2004) [Pubmed]
Metabolic drug interactions with new psychotropic agents. Spina, E., Scordo, M.G., D'Arrigo, C. Fundam. Clin. Pharmacol (2003) [Pubmed]
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction. Spina, E., Avenoso, A., Scordo, M.G., Ancione, M., Madia, A., Gatti, G., Perucca, E. J. Clin. Psychopharmacol (2002) [Pubmed]
Newer antipsychotics: comparative review of drug interactions. Spina, E., Scordo, M.G. Expert. Rev. Neurother (2001) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.